Pioglitazone therapy is associated with improvements in diabetic dyslipidemia

被引：0
|
作者：
Hood, RC
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A476 / A476
页数：1
相关论文
共 50 条
  • [1] Ezetimibe therapy is associated with improvements in diabetic dyslipidemia
    Hood, RC
    DIABETES, 2004, 53 : A230 - A230
  • [2] Diabetic dyslipidemia and its therapy
    Garg, A
    Grundy, SM
    DIABETES REVIEWS, 1997, 5 (04): : 425 - 433
  • [3] Effects of pioglitazone and rosiglitazone on diabetic dyslipidemia by gender: Results from GLAI
    Perez, Alfonso
    Kupfer, Stuart
    Tan, Meng
    Jacober, Scott
    Gbenado, Seth
    DIABETES, 2007, 56 : A236 - A236
  • [4] Pioglitazone Associated Diabetic Macular Oedema
    Gokce, G.
    Durukan, A. H.
    Erdurman, F. C.
    Ceylan, O. M.
    Sobaci, G.
    WEST INDIAN MEDICAL JOURNAL, 2012, 61 (06): : 648 - 649
  • [5] Statin therapy for the treatment of diabetic dyslipidemia
    Haffner, SM
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2003, 19 (04) : 280 - 287
  • [6] Diabetic dyslipidemia: A practical guide to therapy
    Tovar, John M.
    Bazaldua, Oralia V.
    Loffredo, Alexandra
    JOURNAL OF FAMILY PRACTICE, 2008, 57 (06): : 377 - 388
  • [7] Role for Combination Therapy in Diabetic Dyslipidemia
    Warraich, Haider J.
    Wong, Nathan D.
    Rana, Jamal S.
    CURRENT CARDIOLOGY REPORTS, 2015, 17 (05)
  • [8] Role for Combination Therapy in Diabetic Dyslipidemia
    Haider J. Warraich
    Nathan D. Wong
    Jamal S. Rana
    Current Cardiology Reports, 2015, 17
  • [9] Pioglitazone attenuates cardiometabolic risk factors in non-diabetic patients with dyslipidemia
    Hussain, Mazhar
    Shad, Muhammad Nauman
    Akhtar, Lubna
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2017, 67 (12) : 1884 - 1888
  • [10] Effect of intensive diabetes therapy on diabetic dyslipidemia
    Purnell, JQ
    Brunzell, JD
    DIABETES REVIEWS, 1997, 5 (04): : 434 - 444
12345